Tags: Zika Virus | Health | Zika | US | vaccine | research

Zika Vaccines Show Promise in Monkey Studies

Image: Zika Vaccines Show Promise in Monkey Studies

(Copyright Fotolia)

Friday, 23 Sep 2016 08:13 AM

A pair of experimental vaccines being developed by the US National Institutes of Health protected monkeys against Zika virus infection after two doses, researchers said Thursday.

One of the vaccines, known as VRC5288, has already begun early trials in humans to test safety and efficacy, according to a study published in Science.

A phase 2 trial in Zika-endemic countries could begin next year, officials said.

The second vaccine (VRC5283) is awaiting a Phase 1 clinical trial start date.

The research involved vaccinating rhesus macaques using "the two different experimental Zika DNA vaccines in different doses," said the NIH in a statement.

Two doses were "highly effective" at protecting macaques exposed to an infectious dose of Zika virus.

Experts say it will be years before a vaccine is developed to prevent infection from Zika, which is particularly dangerous to pregnant women because it can cause brain defects in the fetus.

 

 

© AFP 2017

   
1Like our page
2Share
Health-News
A pair of experimental vaccines being developed by the US National Institutes of Health protected monkeys against Zika virus infection after two doses, researchers said Thursday.One of the vaccines, known as VRC5288, has already begun early trials in humans to test safety...
Health, Zika, US, vaccine, research
149
2016-13-23
Friday, 23 Sep 2016 08:13 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved